Dr. Warshawsky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6000 W Creek Rd
Suite 10
Independence, OH 44131Phone+1 800-223-2273
Education & Training
- University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 1996 - 1999
- Washington University in St. Louis School of MedicineClass of 1996
Certifications & Licensure
- OH State Medical License 2000 - 2025
- WI State Medical License 2012 - 2015
- PA State Medical License 1997 - 2000
- American Board of Pathology Clinical Pathology
- American Board of Pathology Molecular Genetic Pathology
Publications & Presentations
PubMed
- 55 citationsGlypican-3 is a binding protein on the HepG2 cell surface for tissue factor pathway inhibitor.E. Alan Mast, A. Darryl Higuchi, Zhong-Fu Huang, Ilka Warshawsky, L. Alan Schwartz
The Biochemical Journal. 1997-10-15 - 22 citationsBiallelic PI4KA variants cause neurological, intestinal and immunological diseaseClaire G. Salter, Yiying Cai, Bernice Lo, Guy Helman, Henry Taylor
Brain. 2021-08-20 - 93 citationsThe low density lipoprotein receptor-related protein mediates the cellular degradation of tissue factor pathway inhibitor.Ilka Warshawsky, George J. Broze, Alan L. Schwartz
Proceedings of the National Academy of Sciences of the United States of America. 1994-07-05
Press Mentions
- A Poorly Framed Article on COVID-19 Vaccine Injury in the New York TimesMay 6th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: